Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia

NCT00439634 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
873
Enrollment
INDUSTRY
Sponsor class

Stopped Following a pre-specified interim analysis and Data Monitoring Committee recommendation due to insufficient level of efficacy

Conditions

Interventions

Sponsor

Sanofi